American Group — Supplies Expense
HCA Healthcare American Group — Supplies Expense increased by 6.6% to $1.12B in Q4 2025 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), American Group — Supplies Expense shows an upward trend with a 13.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to revenue may signal rising medical inflation or inefficiencies in supply chain procurement, while a decrease suggests improved cost controls or favorable vendor pricing.
Detailed definition
This metric represents the total costs incurred for medical and surgical supplies, pharmaceuticals, and other consumable...
Peer comparison
Comparable to 'Cost of Goods Sold' or 'Medical Supplies Expense' at other large-scale hospital systems and healthcare providers.
hca_segment_american_group_supplies_expenseHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $832.75M | $832.75M | $832.75M | $832.75M | $904.00M | $904.00M | $904.00M | $904.00M | $978.00M | $1.01B | $1.02B | $1.07B | $1.05B | $1.12B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +8.6% | +0.0% | +0.0% | +0.0% | +8.2% | +3.0% | +1.3% | +4.6% | -1.3% | +6.6% |
| YoY Change | — | — | — | — | +8.6% | +8.6% | +8.6% | +8.6% | +8.2% | +11.4% | — | +9.1% | +4.6% | — |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is HCA Healthcare's american group — supplies expense?
- HCA Healthcare (HCA) reported american group — supplies expense of $1.12B in Q4 2025.
- What is the long-term trend for HCA Healthcare's american group — supplies expense?
- Over 2 years (2022 to 2025), HCA Healthcare's american group — supplies expense has grown at a 13.1% compound annual growth rate (CAGR), from $3.33B to $4.26B.
- What does american group — supplies expense mean?
- The total cost of medical supplies and pharmaceuticals used to provide patient care within this specific business segment.